1 Walgama E,Sacks WL,Ho AS.Papillary thyroid microcarcinoma:optimal management versus overtreatment[J].Curr Opin Oncol,2020,32(1):1-6. 2 Bergdorf K,Ferguson DC,Mehrad M,et al.Papillary thyroid carcinoma behavior:clues in the tumor microenvironment[J].Endocr Relat Cancer,2019,26(6):601-614. 3 Metovic J,Cabutti F,Osella-Abate S,et al.Clinical and pathological features and gene expression profiles of clinically aggressive papillary thyroid carcinomas[J].Endocr Pathol,2023,34(3):298-310. 4 Higashino M,Ayani Y,Terada T,et al.Clinical features of poorly differentiated thyroid papillary carcinoma[J].Auris Nasus Larynx,2019,46(3):437-442. 5 Caroço TV,Saraiva RP,Baião JM,et al.Mediastinal papillary thyroid carcinoma treated by video-assisted thoracic surgery -case report[J].Int J Surg Case Rep,2023,106:108140. 6 Di Filippo L,Giugliano G,Tagliabue M,et al.Total thyroidectomy versus lobectomy:surgical approach to T1-T2 papillary thyroid cancer[J].Acta Otorhinolaryngol Ital,2020,40(4):254-261. 7 齐艳涛,李宏宇,柴吉鑫,等.双侧甲状腺全切除术与近全切除术后甲状旁腺功能减退的logistic回归分析[J].中国临床医生杂志,2022,50(9):1091-1095. 8 Han L,Li W,Li Y,et al.Total thyroidectomy is superior for initial treatment of thyroid cancer[J].Asia Pac J Clin Oncol,2021,17(5):170-175. 9 穆静辉,冯文静.甲状腺乳头状癌伴发桥本甲状腺炎行甲状腺全切手术后生存质量分析[J].临床外科杂志,2021,29(8):761-763. 10 中国抗癌协会甲状腺癌专业委员会.中国抗癌协会甲状腺癌整合诊治指南(2022精简版)[J].中国肿瘤临床,2023,50(7):325-330. 11 王松祥,阮立为,钱霄君.甲状腺良性疾病行双侧甲状腺近全切除术的临床分析[J].中国现代医学杂志,2015,25(3):59-61. 12 Ponce de León-Ballesteros G,Velázquez-Fernández D,Hernández-Calderón FJ,et al.Hypoparathyroidism after total thyroidectomy:importance of the intraoperative management of the parathyroid glands[J].World J Surg,2019,43(7):1728-1735. 13 Dugani P,Sharma PV,Krishna SM,et al.Serum parathyroid hormone and vitamin d levels as predictors of hypocalcemia after total/ near total thyroidectomy[J].Indian J Otolaryngol Head Neck Surg,2023,75(3):1502-1510. 14 Qiu Y,Xing Z,Xiang Q,et al.Duration of parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy for papillary thyroid carcinoma[J].Front Endocrinol(Lausanne),2021,12:665190. 15 Chen R,Zhang K,Liu J,et al.Preoperative ultrasound identification and localization of the inferior parathyroid glands in thyroid surgery[J].Front Endocrinol(Lausanne),2023,14:1094379. 16 Gao H,Liu X,Yu X,et al.Application of nano-carbon tracing technology in thyroid cancer and its relationship with cytotoxic t lymphocyte antigen 4 gene polymorphism[J].J Nanosci Nanotechnol,2021,21(2):949-954. 17 Dhahri AA,Ahmad R,Rao A,et al.Use of prophylactic steroids to prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy:a randomized clinical trial[J].JAMA Otolaryngol Head Neck Surg,2021,147(10):866-870. 18 Haugen BR,Alexander EK,Bible KC,et al.2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133. 19 D′haeseleer E,Huvenne W,Vermeersch H,et al.Long-term voice quality outcome after thyroidectomy without laryngeal nerve injury:a prospective 10 year follow up study[J].J Commun Disord,2021,91:106109. 20 Lyu YS,Pyo JS,Cho WJ,et al.Clinicopathological significance of papillary thyroid carcinoma located in the isthmus:a meta-analysis[J].World J Surg,2021,45(9):2759-2768. 21 Fan J,Zhou W,Zhan W,et al.Clinical and ultrasonographic features of papillary thyroid carcinoma located in the isthmus[J].Ultrasound Q,2023,39(1):32-36. 22 Gordon AJ,Dublin JC,Patel E,et al.American thyroid association guidelines and national trends in management of papillary thyroid carcinoma[J].JAMA Otolaryngol Head Neck Surg,2022,148(12):1156-1163. 23 Vasileiadis I,Boutzios G,Karalaki M,et al.Papillary thyroid carcinoma of the isthmus:total thyroidectomy or isthmusectomy[J].Am J Surg,2018,216(1):135-139. 24 Filetti S,Durante C,Hartl D,et al.Thyroid cancer:Esmo clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2019,30(12):1856-1883. 25 中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797. 26 中华人民共和国国家卫生健康委员会.甲状腺癌诊疗规范(2018年版)[J].中华普通外科学文献(电子版),2019,13(1):1-15. 27 燕世德,胡开兵,胡钢,等.单侧腺叶切除伴峡部切除术治疗T1/2cN0M0单侧多灶性甲状腺乳头状癌的疗效及安全性分析[J].河北医学,2023,29(2):307-311. 28 Lo CY.Lymph node dissection for papillary thyroid carcinoma[J].Methods Mol Biol,2022,2534:57-78. 29 Alsubaie KM,Alsubaie HM,Alzahrani FR,et al.Prophylactic central neck dissection for clinically node-negative papillary thyroid carcinoma[J].Laryngoscope,2022,132(6):1320-1328. 30 Wang Y,Wu Z,Yan J,et al.Optimal surgical population for cervical lymph node dissection in PTC[J].Front Oncol,2024,14:1280607. 31 Zhang Z,Zhang X,Yin Y,et al.Integrating BRAFV600E mutation,ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma[J].BMC Cancer,2022,22(1):461. 32 Zhong X,Lu Y,Yin X,et al.Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model[J].Gland Surg,2022,11(2):378-388. 33 杨佳欢,陈泽泉,余永利,等.1例伴发骨和肺转移的滤泡型甲状腺乳头状癌经一次131I治疗治愈[J].标记免疫分析与临床,2021,28(5):896-900. 34 Su X,Shang L,Yue C,et al.Ultrasound-guided fine needle aspiration thyroglobulin in the diagnosis of lymph node metastasis of differentiated papillary thyroid carcinoma and its influencing factors[J].Front Endocrinol(Lausanne),2024,15:1304832. 35 Signore A,Lauri C,Di Paolo A,et al.Predictive role of serum thyroglobulin after surgery and before radioactive iodine therapy in patients with thyroid carcinoma[J].Cancers(Basel),2023,15(11):2976. 36 周振华,刘细平,叶亮,等.喉返神经中间入路显露法在腔镜甲状腺腺叶切除中的应用[J].中国普通外科杂志,2021,30(5):531-536. 37 徐娇,邹永红,王敏.甲状腺乳头状癌患者喉返神经旁淋巴结不同清扫方式对围术期指标及喉返神经的影响[J].医学临床研究,2023,40(7):1018-1020. 38 Lee HS,Kim Y,Kim SB,et al.Shaving papillary thyroid carcinoma involving functioning recurrent laryngeal nerve:safety of incomplete tumor resection and nerve sparing[J].Ann Surg Oncol,2023,30(12):7157-7164. 39 Ma Y,Zeng C,Hou P,et al.Pseudomonas aeruginosa injection decreases drainage in lateral neck dissection for metastatic thyroid cancer[J].Gland Surg,2020,9(5):1543-1550. 40 张雅婷,陈梦圆,王一帆,等.开放手术与完全腔镜手术治疗早期甲状腺乳头状癌的淋巴结清扫效果对比分析[J].腹腔镜外科杂志,2023,28(3):181-185. 41 Van Sonnenberg E,Simeone JF.Microwave ablation versus surgery for papillary thyroid carcinoma:More therapeutic options,more controversies[J].Radiology,2022,304(3):714-715. 42 Wei Y,Niu WQ,Zhao ZL,et al.Microwave ablation versus surgical resection for solitary t1n0m0 papillary thyroid carcinoma[J].Radiology,2022,304(3):704-713. 43 Yan H,Wang Y,Huang P,et al.Scarless neck endoscopic thyroidectomy via the breast approach:a preliminary report of 45 cases with total or near-total thyroidectomy plus central compartment dissection[J].Niger J Clin Pract,2019,22(12):1772-1777. 44 Zhang R,Chen Y,Deng X,et al.Comparison of bilateral axillo-breast approach robotic thyroidectomy and open thyroidectomy for papillary thyroid carcinoma[J].J Robot Surg,2023,17(5):1933-1942. 45 He L,Wang W,Sheng JF.A case report of ectopic thyroid adenoma resection by transaxillary non-inflatable endoscopic surgery[J].Int J Surg Case Rep,2024,114:109181. 46 Ma T,Shi P,Zhang X,et al.Transoral and submental endoscopic thyroidectomy(TOaST)for early stage papillary thyroid carcinoma:a real-world data retrospective cohort study[J].Surg Endosc,2023,37(10):7649-7657. 47 王斌,陈洪丽,马骁.不同切口在肥胖女性甲状腺乳头状癌根治术中的应用效果比较[J].广西医学,2023,45(17):2079-2082. |